17 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
12 Aug 21
Verve Therapeutics Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results
8:20am
few years making progress on our mission, and in non-human primate studies, have shown that with just a single treatment of our base editor targeting
8-K
EX-99.1
VERV
Verve Therapeutics Inc
10 May 22
Verve on Track to Begin Dosing HeFH Patients in New Zealand in Mid-2022 in a Phase 1 Clinical Trial with Initial Clinical Data Expected in 2023
6:48am
to rapidly submit our IND upon completion. This is a momentous year as we continue our mission of transforming the treatment of cardiovascular disease
8-K
EX-99.1
VERV
Verve Therapeutics Inc
8 May 24
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
7:15am
March 31, 2024.
“Our accomplishments in the first quarter bring us closer to realizing our mission of protecting patients from cardiovascular
8-K
EX-99.1
VERV
Verve Therapeutics Inc
27 Feb 24
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
.
“2023 was a momentous year for Verve as we made significant strides towards our mission of protecting the world from cardiovascular disease. Our
DRS
EX-10.16
VERV
Verve Therapeutics Inc
16 Apr 21
Draft registration statement
12:00am
”), the company you helped us to get up and running! It has been a pleasure to work with you and I look forward to working together on Verve’s mission
S-1
EX-10.15
i9z6m3 ch
28 May 21
IPO registration
4:04pm
DRS
EX-10.17
554j4eattib iui
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.16
q00acnlnk
28 May 21
IPO registration
4:04pm
DRS
EX-10.15
9x5nxam9k1f6wqvz0
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.14
0jf33ngwn
28 May 21
IPO registration
4:04pm
10-K
do6 asgcpj
14 Mar 22
Annual report
7:04am
S-1
23k7 z9l07zoxiqdyc
28 May 21
IPO registration
4:04pm
S-1/A
s3wa xfhfd
14 Jun 21
IPO registration (amended)
6:15am
DRS
078yet ly9
16 Apr 21
Draft registration statement
12:00am
424B4
eag5e
17 Jun 21
Prospectus supplement with pricing info
4:50pm
- Prev
- 1
- Next